About the Product

Description


Cefzlan L Tablet containing Cefixime and Linezolid is used for the management of susceptible bacterial infections. It helps control bacterial growth and supports effective recovery from infection-related conditions.

Cefixime works as a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Linezolid works by inhibiting bacterial protein synthesis. Together, they provide broad-spectrum antibacterial coverage against susceptible organisms.

The tablet is prescribed in clinical practice for the management of various bacterial infections where combination antibiotic therapy is considered appropriate, leading to consistent prescription demand.

With the continued need for effective antibacterial therapies and growing demand for advanced infection management solutions, this product offers strong business potential for retailers and distributors. Its combination formulation, established therapeutic relevance, and steady market demand make it a reliable product for growth in the anti-infective segment.

Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, headache, dizziness, or altered taste sensation. Rarely, bone marrow suppression, thrombocytopenia, peripheral neuropathy, optic neuropathy, severe allergic reactions, or serotonin syndrome may occur and require immediate medical attention.

Cefzlan L Tablet is indicated for respiratory tract infections, skin and soft tissue infections, urinary tract infections, ear, nose and throat infections, and other bacterial infections caused by susceptible organisms as prescribed by a healthcare professional. It helps eliminate infection-causing bacteria, reduce symptoms, and support faster recovery.

This medicine should be used strictly under medical supervision. Complete the full prescribed course even if symptoms improve earlier to help prevent antibiotic resistance. Prolonged use of Linezolid may require monitoring of blood counts and vision. Use cautiously in patients with kidney disease, blood disorders, hypertension, or those taking antidepressants and other serotonergic medications.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Cefixime 200mg + Linezolid 600mg Tablet in the PCD pharma franchise market?

Cefixime 200mg + Linezolid 600mg Tablet has strong demand in the anti-infective, critical care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced antibiotic and specialty care portfolios.

Why should medical distributors include Cefixime + Linezolid Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for bacterial infection management under medical supervision. Cefixime 200mg is a third-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Linezolid 600mg is an oxazolidinone antibiotic commonly used against susceptible Gram-positive bacterial infections Commonly prescribed for respiratory tract infections, skin and soft tissue infections, and other bacterial infections as determined by healthcare professionals Offers broad antimicrobial coverage and is often utilized in specialty and critical care settings This strengthens a comprehensive anti-infective and hospital-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefixime 200mg + Linezolid 600mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong prescription demand, growing requirements in anti-infective therapy, repeat business opportunities, reliable supply chain support, and attractive margins in the specialty antibiotic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.